Drugs · acquisition-cost intelligence
CVS Pharmacy
(saline)· ingredient sodium phosphate, monobasic· SODIUM PHOSPHATE, DIBASIC 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC 19 g/118mL; SODIUM PHOSPHATE, DIBASIC 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM 19 g/118mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 3.5 g/66mL; SODIUM PHOSPHATE, MONOBASIC 9.5 g/66mL; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 7 g/118mL; SODIUM PHOSPHATE, MONOBASIC 19 g/118mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.00637
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other sodium phosphate, monobasic products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| K Phos Neutral | $0.29006 | +$0.28370 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.